About this trial
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
Eligibility criteria
Qualifiers
Patients with inflammatory or cystic exocrine pancreatic pathology
Patient able to read and understand the information leaflet
Patients who have agreed to participate in the study and have signed the free and informed consent
Patients affiliated to a social security system (including AME)
Disqualifiers
Patient with pancreatic cancer pathology
Patients with active cancer, whatever the origin
Pregnant or breastfeeding patients
Patients under legal protection, guardianship or trusteeship
Trial design
Treatments tested in this trial
- Not listed